Buzone Conc. 266.66 mg

Buzone Conc. 266.66 mg is a powdered formulation of phenylbutazone, commonly used for pain relief and inflammation management in animals. This oral medication is manufactured by Can-Vet Animal Health Supplies Ltd. in Canada.

Buzone Conc. 266.66 mg is primarily used for managing pain and reducing inflammation in animals. Phenylbutazone, the active ingredient, is often administered to alleviate discomfort associated with musculoskeletal issues. This medication is suitable for oral administration and is commonly prescribed by veterinarians for conditions requiring anti-inflammatory support.

When administered as directed, Buzone Conc. 266.66 mg may help reduce pain and inflammation in animals. The effects of phenylbutazone typically include relief from discomfort and improved mobility. However, individual responses can vary, and it is important to monitor the animal for any adverse reactions.

Buzone Conc. 266.66 mg should be handled with care and stored in a cool, dry place away from direct sunlight. It is essential to follow the veterinarian's instructions regarding dosage and administration. Ensure the animal has access to plenty of water while on this medication to support kidney function.

Phenylbutazone may interact with other medications, including non-steroidal anti-inflammatory drugs (NSAIDs) and certain antibiotics. It is important to inform your veterinarian about all medications your animal is currently taking to avoid potential interactions. Additionally, alcohol and other sedatives should be avoided unless specifically advised by a healthcare professional.